🗣 FEES Endoscopic Swallowing Evaluation Simulator

Transnasal Endoscopy & Baseline Secretion Assessment

Fiberoptic Endoscopic Evaluation of Swallowing (FEES) begins before a single drop of liquid is offered. A thin flexible endoscope is passed through the nose to sit just above the epiglottis, giving a direct, well-lit view of the pharynx and larynx. What the clinician sees at rest — how much saliva has pooled, and where — is itself a powerful, validated predictor of aspiration risk.

• 2.4–3.9 mm: Scope outer diameter (flexible rhino-laryngoscope)
• 88–93%: FEES sensitivity for aspiration (vs videofluoroscopy reference)
• 0–4: Murray Secretion Scale range (0 = none, 4 = severe + aspirated)
• 10–20 min: Typical exam duration (bedside or clinic, no sedation)

Equipment and insertion technique

The FEES endoscope is a flexible fiberoptic or distal-chip laryngoscope, 2.4–3.9 mm in outer diameter, connected to a light source, camera processor, and monitor (increasingly with synchronized audio and simultaneous digital recording). The scope is passed transnasally along the floor of the nose or through the middle meatus, guided past the nasopharynx and soft palate, and parked in the oropharynx just superior to the epiglottis.

Topical decongestant and/or anesthetic spray is sometimes used to ease passage, though many protocols avoid pharyngeal anesthesia entirely because it can blunt sensation and artificially mask swallowing dysfunction. From this vantage point the scope delivers a panoramic, well-illuminated view of the base of tongue, epiglottis, valleculae, pyriform sinuses, arytenoids, and vocal folds — the entire pharyngeal and laryngeal stage on which swallowing plays out.

The Murray Secretion Scale

Before any bolus is given, the clinician scores resting secretions using the Murray Secretion Scale, a simple 5-point ordinal scale (0–4):

0 — No pooled secretions visible 1 — Mild pooling, confined to a single site (valleculae or pyriform sinus) 2 — Moderate pooling across multiple sites, not contacting the airway entrance 3 — Severe pooling that contacts the laryngeal vestibule or vocal folds 4 — Severe pooling with frank penetration or aspiration of secretions below the vocal folds

Murray's original 1996 validation work found this baseline score correlates strongly with subsequent aspiration risk on bolus trials — patients who cannot manage their own saliva are unlikely to manage food or liquid any better.

Secretions pooling before any food or liquid is given are themselves a validated predictor of aspiration risk — patients scoring Murray Scale ≥3 have significantly higher rates of aspirating the boluses that follow.

Baseline laryngopharyngeal examination

Beyond secretions, the baseline pass documents vocal fold mobility and symmetry during phonation, structural findings (masses, edema, scarring, post-surgical changes), and — where equipment allows — laryngopharyngeal sensory testing (FEESST), in which a calibrated pulse of air is delivered to the aryepiglottic fold to elicit the laryngeal adductor reflex. Absent or markedly elevated sensory thresholds flag patients at high risk for silent aspiration later in the exam, since they may not sense material entering the airway.

Dyed Bolus Administration & Pre-Swallow View

With baseline secretions documented, the patient is offered a graduated series of boluses — liquids and foods dyed green for contrast against the pink pharyngeal mucosa. The clinician watches closely for what happens before the swallow ever triggers, because premature spillage of the bolus is itself a meaningful finding.

• 0–7: IDDSI consistency levels tested (thin liquid through regular solids)
• 3–20 mL: Typical bolus volumes (teaspoon to cup sip trials)
• Green dye: Standard tracer color (high contrast vs mucosa)
• <1 sec: Pre-trigger spillage window (oral containment deficit sign)

Consistency trials and the IDDSI framework

Boluses are typically presented in graduated order — thin liquid, mildly thick (nectar), moderately thick (honey), and pureed or solid textures — following the International Dysphagia Diet Standardisation Initiative (IDDSI) framework of eight numbered levels (0 Thin through 7 Regular). Volumes escalate within each consistency, from a small controlled teaspoon to a free cup sip, and from a single cracker bite to a sequential eating trial, always starting conservatively and stopping immediately if aspiration or significant distress is observed.

Dye selection and visualization

Green food coloring is the modern standard tracer because it produces strong visual contrast against the salmon-pink pharyngeal and laryngeal mucosa under endoscopic light, is inexpensive, and is safe in the small volumes used diagnostically. Blue dye was historically used in some centers but fell out of favor after case reports of systemic effects when large volumes were used for prolonged enteral-tube monitoring — a different clinical context, but one that nonetheless shifted diagnostic practice toward green as the safer convention.

Pre-swallow events — the oral phase, seen from behind

FEES cannot see the oral cavity directly (the scope sits in the pharynx, behind the action), but it captures the pharyngeal consequence of oral phase control. As the bolus is manipulated on the tongue, the clinician watches the valleculae and pyriform sinuses for premature spillage — dye trickling over the base of tongue and pooling in the pharynx before the swallow has triggered. This indicates impaired oral containment or a delayed swallow trigger, and it matters because material sitting in the open pharynx before airway closure is material that can fall straight into an unprotected airway.

Premature spillage correlates strongly with delayed pharyngeal swallow triggering and is disproportionately common with thin liquids — the fastest-moving, least controllable consistency.

Pharyngeal Swallow & the White-Out Moment

The instant the pharyngeal swallow triggers, the view on the monitor briefly disappears into a wash of white or pink as the constricting pharyngeal walls close entirely around the scope lens. Far from being a technical glitch, this "white-out" is a genuine diagnostic sign — its presence, timing, and duration all carry clinical meaning.

• 0.3–0.5 sec: White-out duration (typical normal swallow)
• 0.4–1.0 sec: Pharyngeal trigger latency (from bolus at valleculae)
• ~2 cm: Hyolaryngeal excursion (not directly visualized by FEES)
• 30–60 fps: Endoscope frame rate (standard to HD-chip scopes)

Mechanics of the white-out

A normal pharyngeal swallow is a rapid, forceful, circumferential event: the superior, middle, and inferior pharyngeal constrictors contract in a stripping wave, the tongue base retracts firmly against the posterior pharyngeal wall, and the epiglottis inverts down over the laryngeal inlet while the larynx elevates and closes. All of this tissue converges on and around the scope lens simultaneously, physically occluding the camera's view — producing the sudden white or pink-out that marks every normally triggered pharyngeal swallow.

What the white-out confirms — and what it hides

A crisp, brief white-out is reassuring: it confirms the pharyngeal swallow response triggered and that the constrictors achieved full tissue apposition around the scope. But it is also FEES' one genuine blind spot — the exact moment of laryngeal vestibule closure and upper esophageal sphincter (UES) opening is physically hidden from the lens during that fraction of a second. This is the one thing videofluoroscopy (MBSS) sees that FEES structurally cannot, since fluoroscopy visualizes the entire swallow, including the hidden phase, in continuous x-ray silhouette.

The white-out is often mistaken for a technical flaw, but its presence and duration are themselves diagnostic — a brief, complete white-out signals a strong pharyngeal squeeze, while an incomplete, prolonged, or absent white-out suggests weak or discoordinated pharyngeal contraction.

Timing analysis and clinical interpretation

Clinicians reviewing FEES recordings frame-by-frame measure the interval from bolus arrival at the valleculae to white-out onset (an approximation of pharyngeal swallow delay), and the white-out's own duration. Delayed onset points to a sluggish or absent trigger — often the mechanism behind premature spillage seen in Stage 2 — while a shortened or incomplete white-out points to weak constrictor contraction, a mechanism that reliably predicts the post-swallow residue assessed in Stage 4.

Post-Swallow Residue Assessment — Valleculae & Pyriform Sinus

As the white-out clears and the view returns, the clinician surveys the pharynx for any dye left behind. Residue pooled in the valleculae or pyriform sinuses after the swallow is graded on a validated scale and, because FEES carries no radiation dose limit, can be re-examined across as many repeat swallows and compensatory maneuvers as needed.

• 0–4: Yale Residue Scale range (valleculae & pyriform, scored separately)
• >50% fill: High-risk residue threshold (linked to post-swallow aspiration)
• ICC > 0.80: Inter-rater reliability (good-to-excellent agreement)
• ≈ Even: Residue site split (valleculae vs pyriform, pathology-dependent)

The Yale Pharyngeal Residue Severity Rating Scale

The Yale scale grades residue independently in the valleculae and the pyriform sinuses (bilaterally where relevant), using consistent visual fill anchors:

0 — None visible 1 — Trace, a thin coating only 2 — Mild, less than 25% of the space filled 3 — Moderate, 25–50% filled 4 — Severe, more than 50% filled

Because the anchors are tied to a visible percentage of the pocket's volume rather than a subjective impression, the scale achieves good-to-excellent inter-rater reliability across trained raters, making it suitable for tracking a single patient's recovery over serial exams.

Clinical significance of residue location

Where residue collects is a clue to which part of the swallow failed. Vallecular residue (anterior to the epiglottis, at the base of tongue) typically reflects reduced tongue base retraction or weak posterior tongue-to-pharyngeal-wall contact. Pyriform sinus residue (lateral to the larynx, leading into the esophagus) more often reflects reduced pharyngeal constrictor contraction or incomplete upper esophageal sphincter opening — a cricopharyngeal problem. Asymmetric pyriform residue, filling one side more than the other, raises suspicion for a unilateral pharyngeal weakness, often from stroke or cranial nerve injury.

Multiple swallows and clearance strategies

Because FEES has no cumulative radiation dose to manage, the clinician can trial repeat dry swallows, a chin-tuck posture, head rotation toward the weaker side, an effortful swallow, or a supraglottic swallow maneuver — all live, on the same bolus of residue — and watch in real time whether the pocket clears. This turns the exam into an immediate treatment trial as well as a diagnostic one, letting the team select compensatory strategies that are proven to work for this specific patient before ever leaving the room.

Because FEES carries zero radiation exposure, clinicians can trial unlimited swallows and compensatory maneuvers in real time — a luxury not available under fluoroscopy's dose limits.

FEES vs. Videofluoroscopy (MBSS) — clinical comparison

Penetration–Aspiration Scoring & Clinical Recommendations

The final and highest-stakes observation is whether dye tracks into the laryngeal vestibule or past the vocal folds into the trachea. This is graded on the 8-point Penetration-Aspiration Scale, and — because roughly a third of aspirating patients show no cough at all — direct endoscopic visualization below the folds is often the only way to catch it.

• 1–8: PAS scale range (Rosenbaum & Robbins, 1996)
• 25–40%: Silent aspiration prevalence (of aspirators show no cough)
• 88% / 92%: FEES sensitivity / specificity (vs MBSS reference, aspiration detection)
• 35–45%: Diet modification after FEES (of dysphagia referrals)

The Penetration-Aspiration Scale (PAS)

The PAS is an 8-point ordinal scale describing exactly how far material travels toward — and into — the airway, and how the patient responds:

1 — No penetration, material stays above the vocal folds 2–3 — Penetration into the laryngeal vestibule, above the folds, ejected or cleared 4–5 — Penetration contacting or reaching the vocal folds, with or without a cough response 6 — Aspiration below the vocal folds, but material is ejected from the airway 7 — Aspiration below the vocal folds, no spontaneous ejection despite effort 8 — Aspiration below the vocal folds with no cough or any visible reaction — silent aspiration

Higher scores are progressively more dangerous, and the scale's granularity lets clinicians track subtle improvement or decline between exams that a simple "aspirated / did not aspirate" label would miss.

Silent aspiration and why direct visualization matters

Roughly a quarter to two-fifths of patients who aspirate do so silently — with no cough, no voice change, no visible distress — meaning a bedside clinical swallow exam that relies on those cues alone will miss them entirely. Because FEES places a camera directly above the vocal folds and can look below them in the moments after the swallow, it directly visualizes dye entering the trachea regardless of whether the patient reacts, making it one of the few tools capable of reliably catching silent aspiration.

Translating findings into clinical recommendations

Every finding from the exam — Murray Secretion Scale, spillage pattern, white-out quality, Yale residue grade, and PAS score — feeds a single treatment plan. Typical outputs include: selecting a safe IDDSI diet texture level, prescribing compensatory strategies already validated live during the exam (chin tuck, head turn, effortful or supraglottic swallow), deciding whether oral intake should pause (NPO) in favor of alternative nutrition (NG or PEG feeding) for severe or high-risk findings, referring for dedicated swallowing therapy, and scheduling a repeat FEES to re-score progress once therapy is underway.

A PAS score of 6–8 with silent aspiration on thin liquids, especially combined with a Murray Secretion Scale of 3 or higher, is one of the strongest FEES-derived predictors of aspiration pneumonia risk — often prompting an immediate NPO recommendation pending therapy.